Glibornuride
|drugBox=
WikiDoc Resources for Glibornuride |
Articles |
---|
Most recent articles on Glibornuride Most cited articles on Glibornuride |
Media |
Powerpoint slides on Glibornuride |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Glibornuride at Clinical Trials.gov Clinical Trials on Glibornuride at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Glibornuride
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Glibornuride Discussion groups on Glibornuride Patient Handouts on Glibornuride Directions to Hospitals Treating Glibornuride Risk calculators and risk factors for Glibornuride
|
Healthcare Provider Resources |
Causes & Risk Factors for Glibornuride |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Glibornuride (INN) is an anti-diabetic drug from the group of sulfonylureas.[1]
References
- ↑ Haupt E, Köberich W, Beyer J, Schöffling K (December 1971). "Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects". Diabetologia. 7 (6): 449–54. doi:10.1007/bf01212061. PMID 5004178.